Beijing Yuding Additive Manufacturing Research Institute Co., Ltd. announced that it has received funding from CGII Private Fund Co., Ltd, Xi'an CAS Star Technology Incubator Co., Ltd., SDIC Unity Capital Co., Ltd., Lepu Medical Technology Co., Ltd., China Xiong'an Group Fund Management Co., Ltd.
April 29, 2024
Share
Beijing Yuding Additive Manufacturing Research Institute Co., Ltd. announced that it has received funding on April 30, 2024. The transaction included participation from returning investors CGII Geographic Information Equity Investment Fund, a fund managed by CGII Private Fund Co., Ltd, new investors Xi'an CAS Star Technology Incubator Co., Ltd., SDIC Unity Capital Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd. and China Xiong'an Group Fund Management Co., Ltd.
Lepu Medical Technology (Beijing) Co., Ltd. specialized in the design, manufacture and marketing of medical devices and equipment. The group is also involved in the development and manufacturing of active pharmaceutical ingredients. Net sales break down by activity as follows:
- sale of medical devices and instruments (57.9%): primarily for cardiovascular interventions, cardiac surgery, cardiac rhythm management, anesthesia, intensive care, in vitro diagnostics and general surgery;
- sale of active pharmaceutical ingredients (30.6%): for the manufacturing of pharmaceutical products in the fields of cardiovascular diseases, infectious diseases, oncology, central nervous system disorders, etc.;
- sale of digital health and hospital network management solutions (11.6%).
China accounts for 64.7% of net sales.
Beijing Yuding Additive Manufacturing Research Institute Co., Ltd. announced that it has received funding from CGII Private Fund Co., Ltd, Xi'an CAS Star Technology Incubator Co., Ltd., SDIC Unity Capital Co., Ltd., Lepu Medical Technology Co., Ltd., China Xiong'an Group Fund Management Co., Ltd.
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 
